Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015.

about

Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015.

Item

http://www.wikidata.org/entity/Q47559872

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Indicators and Qualitative Ass ...... rvice (HIRA) of Korea in 2015.

@en

Indicators and Qualitative Ass ...... Review and Assessment Service

@nl

type

Item

label

Indicators and Qualitative Ass ...... rvice (HIRA) of Korea in 2015.

@en

Indicators and Qualitative Ass ...... Review and Assessment Service

@nl

prefLabel

Indicators and Qualitative Ass ...... rvice (HIRA) of Korea in 2015.

@en

Indicators and Qualitative Ass ...... Review and Assessment Service

@nl

P1476

Indicators and Qualitative Ass ...... ervice (HIRA) of Korea in 2015

@en

P2093

Chang Dong Yeo

http://www.w3.org/2001/XMLSchema#string

Heae Surng Park

http://www.w3.org/2001/XMLSchema#string

Ik Jae Lee

http://www.w3.org/2001/XMLSchema#string

Myoung Kyu Lee

http://www.w3.org/2001/XMLSchema#string

Seung Hyeun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance and Strategies to Overcome Resistance in Lung Adenocarcinoma

Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition)

Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer

Epidermal growth factor receptor mutations in lung cancer

Thin-section multiplanar reformats from multidetector-row CT data: utility for assessment of regional tumor extent in non-small cell lung cancer.

Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.

Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

P304

19-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4046/TRD.2017.0112

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eun Young Kim

Yoon Soo Chang

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29332321

http://www.w3.org/2001/XMLSchema#string

P932

5771743

http://www.w3.org/2001/XMLSchema#string